|
|
|
|
| LEADER |
01048nas a22002532 4500 |
| 001 |
ebs66778357e |
| 003 |
EBZ |
| 006 |
m d |||||| |
| 007 |
cr|unu|||||||| |
| 008 |
200707| xx uu p s 0 0eng d |
| 035 |
|
|
|a (EBZ)ebs66778357e
|
| 040 |
|
|
|a EBZ
|
| 042 |
|
|
|a msc
|
| 050 |
0 |
0 |
|a RM
|
| 130 |
0 |
|
|a Black Book - Multiple Myeloma: Patients, Penetration Price & Duration Offer Upside for Celgene Through 2015 (Online)
|
| 222 |
1 |
0 |
|a Black Book - Multiple Myeloma: Patients, Penetration Price & Duration Offer Upside for Celgene Through 2015
|
| 245 |
0 |
0 |
|a Black Book - Multiple Myeloma: Patients, Penetration Price & Duration Offer Upside for Celgene Through 2015
|h [electronic resource].
|
| 260 |
|
|
|b Bernstein Global Wealth Management
|
| 650 |
0 |
7 |
|a Therapeutics
|2 EBSCO-TLI
|
| 773 |
0 |
|
|t Business Source Complete
|d EBSCO
|
| 856 |
4 |
0 |
|3 Full text available: Apr 2011-.
|z Available in Business Source Complete.
|u https://search.ebscohost.com/direct.asp?db=bth&jid=%22BMS9%22&scope=site
|
| 999 |
|
|
|c 99004
|d 99004
|
| 942 |
|
|
|z EBS
|
| 942 |
|
|
|c REL
|